Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week

COPENHAGEN, Denmark, January 7, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will present at the Biotech Showcase conference taking place from January 12-14, 2026, in San Francisco, California. CEO Helen Tayton-Martin will present Evaxion’s 2026 company milestones and provide a company update on January 13, 2026. The Biotech Showcase conference coincides with the J.P. Morgan Healthcare Conference and Evaxion will ...